These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 1967441)

  • 41. Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses.
    Moher D; Cook DJ; Jadad AR; Tugwell P; Moher M; Jones A; Pham B; Klassen TP
    Health Technol Assess; 1999; 3(12):i-iv, 1-98. PubMed ID: 10374081
    [No Abstract]   [Full Text] [Related]  

  • 42. Randomised controlled trials may have many unrecognised potential biases.
    Hawkes N
    BMJ; 2018 Apr; 361():k1561. PubMed ID: 29622530
    [No Abstract]   [Full Text] [Related]  

  • 43. A review of the use of covariates in cluster randomized trials uncovers marked discrepancies between guidance and practice.
    Wright N; Ivers N; Eldridge S; Taljaard M; Bremner S
    J Clin Epidemiol; 2015 Jun; 68(6):603-9. PubMed ID: 25648791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of industry collaboration on randomised controlled trials in oncology.
    Linker A; Yang A; Roper N; Whitaker E; Korenstein D
    Eur J Cancer; 2017 Feb; 72():71-77. PubMed ID: 28027518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantity, topics, methods and findings of randomised controlled trials published by German university departments of general practice - systematic review.
    Heinmüller S; Schneider A; Linde K;
    Trials; 2016 Apr; 17(1):211. PubMed ID: 27107809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methodological bias in cluster randomised trials.
    Hahn S; Puffer S; Torgerson DJ; Watson J
    BMC Med Res Methodol; 2005 Mar; 5():10. PubMed ID: 15743523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Roaming through the methodology. XX. Randomization as a means of avoiding confounding through indication].
    Zielhuis GA
    Ned Tijdschr Geneeskd; 2000 Aug; 144(32):1528-31. PubMed ID: 10949635
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Case studies, single-subject research, and N of 1 randomized trials: comparisons and contrasts.
    Backman CL; Harris SR
    Am J Phys Med Rehabil; 1999; 78(2):170-6. PubMed ID: 10088595
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of Selection Bias on Treatment Effect Size Estimates in Randomized Trials of Oral Health Interventions: A Meta-epidemiological Study.
    Saltaji H; Armijo-Olivo S; Cummings GG; Amin M; da Costa BR; Flores-Mir C
    J Dent Res; 2018 Jan; 97(1):5-13. PubMed ID: 28813182
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reinventing the wheel will not make it rounder: controlled trials of homeopathy reconsidered.
    Walach H
    J Altern Complement Med; 2003 Feb; 9(1):7-13. PubMed ID: 12683353
    [No Abstract]   [Full Text] [Related]  

  • 51. Reporting on data monitoring committees in neonatal randomised controlled trials is inconsistent.
    Perrem LM; Gosling S; Ravikumar I; Khashan AS; Miletin J; Ryan CA; Dempsey E
    Acta Paediatr; 2017 Jan; 106(1):30-33. PubMed ID: 27637413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quality of reporting of randomised controlled trials in the intensive care literature. A systematic analysis of papers published in Intensive Care Medicine over 26 years.
    Latronico N; Botteri M; Minelli C; Zanotti C; Bertolini G; Candiani A
    Intensive Care Med; 2002 Sep; 28(9):1316-23. PubMed ID: 12209283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Problems in the conduct of a randomised clinical trial.
    ter Riet G; Kessels AG; Knipschild P
    J Wound Care; 1998 May; 7(5):259-62. PubMed ID: 9677998
    [No Abstract]   [Full Text] [Related]  

  • 54. A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature.
    Scales CD; Norris RD; Keitz SA; Peterson BL; Preminger GM; Vieweg J; Dahm P
    J Urol; 2007 Mar; 177(3):1090-4; discussion 1094-5. PubMed ID: 17296417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies.
    Li X; Meng X; Timofeeva M; Tzoulaki I; Tsilidis KK; Ioannidis JP; Campbell H; Theodoratou E
    BMJ; 2017 Jun; 357():j2376. PubMed ID: 28592419
    [No Abstract]   [Full Text] [Related]  

  • 56. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052
    [No Abstract]   [Full Text] [Related]  

  • 57. [Pre-randomisation in study designs: getting past the taboo].
    Schellings R; Kessels AG; Sturmans F
    Ned Tijdschr Geneeskd; 2008 Sep; 152(38):2053-6. PubMed ID: 18837179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessing the quality of reports of randomized clinical trials: is blinding necessary?
    Jadad AR; Moore RA; Carroll D; Jenkinson C; Reynolds DJ; Gavaghan DJ; McQuay HJ
    Control Clin Trials; 1996 Feb; 17(1):1-12. PubMed ID: 8721797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improving the completeness and transparency of reports of randomized trials in oral health: the CONSORT statement.
    Needleman I; Worthington H; Moher D; Schulz K; Altman DG
    Am J Dent; 2008 Feb; 21(1):7-12. PubMed ID: 18435368
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improving the quality of reports of randomised controlled trials: the CONSORT statement.
    Otwombe KN; Ogutu B
    East Afr Med J; 2002 Jul; 79(7):394-6. PubMed ID: 12638837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.